1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Epigenomic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Reagents 1.2.3 Kits 1.2.4 Instruments 1.2.5 Enzymes 1.2.6 Services 1.3 Market by Application 1.3.1 Global Epigenomic Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Oncology 1.3.3 Non Oncology 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Epigenomic Market Perspective (2016-2027) 2.2 Epigenomic Growth Trends by Regions 2.2.1 Epigenomic Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Epigenomic Historic Market Share by Regions (2016-2021) 2.2.3 Epigenomic Forecasted Market Size by Regions (2022-2027) 2.3 Epigenomic Industry Dynamic 2.3.1 Epigenomic Market Trends 2.3.2 Epigenomic Market Drivers 2.3.3 Epigenomic Market Challenges 2.3.4 Epigenomic Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Epigenomic Players by Revenue 3.1.1 Global Top Epigenomic Players by Revenue (2016-2021) 3.1.2 Global Epigenomic Revenue Market Share by Players (2016-2021) 3.2 Global Epigenomic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Epigenomic Revenue 3.4 Global Epigenomic Market Concentration Ratio 3.4.1 Global Epigenomic Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Epigenomic Revenue in 2020 3.5 Epigenomic Key Players Head office and Area Served 3.6 Key Players Epigenomic Product Solution and Service 3.7 Date of Enter into Epigenomic Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Epigenomic Breakdown Data by Type 4.1 Global Epigenomic Historic Market Size by Type (2016-2021) 4.2 Global Epigenomic Forecasted Market Size by Type (2022-2027) 5 Epigenomic Breakdown Data by Application 5.1 Global Epigenomic Historic Market Size by Application (2016-2021) 5.2 Global Epigenomic Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Epigenomic Market Size (2016-2027) 6.2 North America Epigenomic Market Size by Type 6.2.1 North America Epigenomic Market Size by Type (2016-2021) 6.2.2 North America Epigenomic Market Size by Type (2022-2027) 6.2.3 North America Epigenomic Market Size by Type (2016-2027) 6.3 North America Epigenomic Market Size by Application 6.3.1 North America Epigenomic Market Size by Application (2016-2021) 6.3.2 North America Epigenomic Market Size by Application (2022-2027) 6.3.3 North America Epigenomic Market Size by Application (2016-2027) 6.4 North America Epigenomic Market Size by Country 6.4.1 North America Epigenomic Market Size by Country (2016-2021) 6.4.2 North America Epigenomic Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Epigenomic Market Size (2016-2027) 7.2 Europe Epigenomic Market Size by Type 7.2.1 Europe Epigenomic Market Size by Type (2016-2021) 7.2.2 Europe Epigenomic Market Size by Type (2022-2027) 7.2.3 Europe Epigenomic Market Size by Type (2016-2027) 7.3 Europe Epigenomic Market Size by Application 7.3.1 Europe Epigenomic Market Size by Application (2016-2021) 7.3.2 Europe Epigenomic Market Size by Application (2022-2027) 7.3.3 Europe Epigenomic Market Size by Application (2016-2027) 7.4 Europe Epigenomic Market Size by Country 7.4.1 Europe Epigenomic Market Size by Country (2016-2021) 7.4.2 Europe Epigenomic Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Epigenomic Market Size (2016-2027) 8.2 Asia-Pacific Epigenomic Market Size by Type 8.2.1 Asia-Pacific Epigenomic Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Epigenomic Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Epigenomic Market Size by Type (2016-2027) 8.3 Asia-Pacific Epigenomic Market Size by Application 8.3.1 Asia-Pacific Epigenomic Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Epigenomic Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Epigenomic Market Size by Application (2016-2027) 8.4 Asia-Pacific Epigenomic Market Size by Region 8.4.1 Asia-Pacific Epigenomic Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Epigenomic Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Epigenomic Market Size (2016-2027) 9.2 Latin America Epigenomic Market Size by Type 9.2.1 Latin America Epigenomic Market Size by Type (2016-2021) 9.2.2 Latin America Epigenomic Market Size by Type (2022-2027) 9.2.3 Latin America Epigenomic Market Size by Type (2016-2027) 9.3 Latin America Epigenomic Market Size by Application 9.3.1 Latin America Epigenomic Market Size by Application (2016-2021) 9.3.2 Latin America Epigenomic Market Size by Application (2022-2027) 9.3.3 Latin America Epigenomic Market Size by Application (2016-2027) 9.4 Latin America Epigenomic Market Size by Country 9.4.1 Latin America Epigenomic Market Size by Country (2016-2021) 9.4.2 Latin America Epigenomic Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Epigenomic Market Size (2016-2027) 10.2 Middle East & Africa Epigenomic Market Size by Type 10.2.1 Middle East & Africa Epigenomic Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Epigenomic Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Epigenomic Market Size by Type (2016-2027) 10.3 Middle East & Africa Epigenomic Market Size by Application 10.3.1 Middle East & Africa Epigenomic Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Epigenomic Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Epigenomic Market Size by Application (2016-2027) 10.4 Middle East & Africa Epigenomic Market Size by Country 10.4.1 Middle East & Africa Epigenomic Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Epigenomic Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche Diagnostics 11.1.1 Roche Diagnostics Company Details 11.1.2 Roche Diagnostics Business Overview 11.1.3 Roche Diagnostics Epigenomic Introduction 11.1.4 Roche Diagnostics Revenue in Epigenomic Business (2016-2021) 11.1.5 Roche Diagnostics Recent Development 11.2 Thermo Fisher Scientific 11.2.1 Thermo Fisher Scientific Company Details 11.2.2 Thermo Fisher Scientific Business Overview 11.2.3 Thermo Fisher Scientific Epigenomic Introduction 11.2.4 Thermo Fisher Scientific Revenue in Epigenomic Business (2016-2021) 11.2.5 Thermo Fisher Scientific Recent Development 11.3 Eisai 11.3.1 Eisai Company Details 11.3.2 Eisai Business Overview 11.3.3 Eisai Epigenomic Introduction 11.3.4 Eisai Revenue in Epigenomic Business (2016-2021) 11.3.5 Eisai Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Epigenomic Introduction 11.4.4 Novartis Revenue in Epigenomic Business (2016-2021) 11.4.5 Novartis Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Epigenomic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Reagents Table 3. Key Players of Kits Table 4. Key Players of Instruments Table 5. Key Players of Enzymes Table 6. Key Players of Services Table 7. Global Epigenomic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Epigenomic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Epigenomic Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Epigenomic Market Share by Regions (2016-2021) Table 11. Global Epigenomic Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Epigenomic Market Share by Regions (2022-2027) Table 13. Epigenomic Market Trends Table 14. Epigenomic Market Drivers Table 15. Epigenomic Market Challenges Table 16. Epigenomic Market Restraints Table 17. Global Epigenomic Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Epigenomic Market Share by Players (2016-2021) Table 19. Global Top Epigenomic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenomic as of 2020) Table 20. Ranking of Global Top Epigenomic Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Epigenomic Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Epigenomic Product Solution and Service Table 24. Date of Enter into Epigenomic Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Epigenomic Market Size by Type (2016-2021) (US$ Million) Table 27. Global Epigenomic Revenue Market Share by Type (2016-2021) Table 28. Global Epigenomic Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Epigenomic Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Epigenomic Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Epigenomic Revenue Market Share by Application (2016-2021) Table 32. Global Epigenomic Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Epigenomic Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Epigenomic Market Size by Type (2016-2021) (US$ Million) Table 35. North America Epigenomic Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Epigenomic Market Size by Application (2016-2021) (US$ Million) Table 37. North America Epigenomic Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Epigenomic Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Epigenomic Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Epigenomic Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Epigenomic Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Epigenomic Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Epigenomic Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Epigenomic Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Epigenomic Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Epigenomic Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Epigenomic Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Epigenomic Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Epigenomic Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Epigenomic Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Epigenomic Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Epigenomic Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Epigenomic Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Epigenomic Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Epigenomic Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Epigenomic Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Epigenomic Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Epigenomic Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Epigenomic Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Epigenomic Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Epigenomic Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Epigenomic Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Epigenomic Market Size by Country (2022-2027) & (US$ Million) Table 64. Roche Diagnostics Company Details Table 65. Roche Diagnostics Business Overview Table 66. Roche Diagnostics Epigenomic Product Table 67. Roche Diagnostics Revenue in Epigenomic Business (2016-2021) & (US$ Million) Table 68. Roche Diagnostics Recent Development Table 69. Thermo Fisher Scientific Company Details Table 70. Thermo Fisher Scientific Business Overview Table 71. Thermo Fisher Scientific Epigenomic Product Table 72. Thermo Fisher Scientific Revenue in Epigenomic Business (2016-2021) & (US$ Million) Table 73. Thermo Fisher Scientific Recent Development Table 74. Eisai Company Details Table 75. Eisai Business Overview Table 76. Eisai Epigenomic Product Table 77. Eisai Revenue in Epigenomic Business (2016-2021) & (US$ Million) Table 78. Eisai Recent Development Table 79. Novartis Company Details Table 80. Novartis Business Overview Table 81. Novartis Epigenomic Product Table 82. Novartis Revenue in Epigenomic Business (2016-2021) & (US$ Million) Table 83. Novartis Recent Development Table 84. Research Programs/Design for This Report Table 85. Key Data Information from Secondary Sources Table 86. Key Data Information from Primary Sources List of Figures Figure 1. Global Epigenomic Market Share by Type: 2020 VS 2027 Figure 2. Reagents Features Figure 3. Kits Features Figure 4. Instruments Features Figure 5. Enzymes Features Figure 6. Services Features Figure 7. Global Epigenomic Market Share by Application: 2020 VS 2027 Figure 8. Oncology Case Studies Figure 9. Non Oncology Case Studies Figure 10. Epigenomic Report Years Considered Figure 11. Global Epigenomic Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Epigenomic Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Epigenomic Market Share by Regions: 2020 VS 2027 Figure 14. Global Epigenomic Market Share by Regions (2022-2027) Figure 15. Global Epigenomic Market Share by Players in 2020 Figure 16. Global Top Epigenomic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenomic as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Epigenomic Revenue in 2020 Figure 18. Global Epigenomic Revenue Market Share by Type (2016-2021) Figure 19. Global Epigenomic Revenue Market Share by Type (2022-2027) Figure 20. North America Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Epigenomic Market Share by Type (2016-2027) Figure 22. North America Epigenomic Market Share by Application (2016-2027) Figure 23. North America Epigenomic Market Share by Country (2016-2027) Figure 24. United States Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Epigenomic Market Share by Type (2016-2027) Figure 28. Europe Epigenomic Market Share by Application (2016-2027) Figure 29. Europe Epigenomic Market Share by Country (2016-2027) Figure 30. Germany Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Epigenomic Market Share by Type (2016-2027) Figure 38. Asia-Pacific Epigenomic Market Share by Application (2016-2027) Figure 39. Asia-Pacific Epigenomic Market Share by Region (2016-2027) Figure 40. China Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Epigenomic Market Share by Type (2016-2027) Figure 48. Latin America Epigenomic Market Share by Application (2016-2027) Figure 49. Latin America Epigenomic Market Share by Country (2016-2027) Figure 50. Mexico Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Epigenomic Market Share by Type (2016-2027) Figure 54. Middle East & Africa Epigenomic Market Share by Application (2016-2027) Figure 55. Middle East & Africa Epigenomic Market Share by Country (2016-2027) Figure 56. Turkey Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Roche Diagnostics Revenue Growth Rate in Epigenomic Business (2016-2021) Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Epigenomic Business (2016-2021) Figure 61. Eisai Revenue Growth Rate in Epigenomic Business (2016-2021) Figure 62. Novartis Revenue Growth Rate in Epigenomic Business (2016-2021) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

Roche Diagnostics Thermo Fisher Scientific Eisai Novartis